Zhengye Biotechnology Holding Ltd
ZYBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001975641
No open-market purchases or sales by Zhengye Biotechnology Holding Ltd insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $68.1K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Zhengye Biotechnology Holding Ltd as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- +1 vs. Q2 2025
- Shares held
- 158.7K
- −261.8K (−62.3%) vs. Q2 2025
- Total value
- $415.9K
- −$2.09M (−83.4%) vs. Q2 2025
- New holders
- 5
- 1 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZYBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $68.1K |
| Q1 2026 | 8 | $113.0K |
| Q4 2025 | 11 | $264.8K |
| Q3 2025 | 10 | $415.9K |
| Q2 2025 | 9 | $2.51M |
| Q1 2025 | 3 | $7.19K |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Zhengye Biotechnology Holding Ltd; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 36,451 | $95.5K | 0.00% | −388−1.1% | Reduced |
| XTX Topco Ltd | 34,589 | $90.6K | 0.00% | +34,589 | New |
| Geode Capital Management, LLC | 29,068 | $76.2K | 0.00% | 00.0% | Unchanged |
| Winton Group Ltd | 21,547 | $56.5K | 0.00% | +21,547 | New |
| Millennium Management LLC | 14,602 | $38.3K | 0.00% | +14,602 | New |
| Citadel Advisors LLC | 11,685 | $30.6K | 0.00% | +11,685 | New |
| Tower Research Capital LLC (TRC) | 4,462 | $11.7K | 0.00% | +1,126+33.8% | Added |
| UBS Group AG | 4,329 | $11.3K | 0.00% | −150,183−97.2% | Reduced |
| Morgan Stanley | 2,009 | $5.26K | 0.00% | −427−17.5% | Reduced |
| Caitong International Asset Management Co., Ltd | 1 | $3 | 0.00% | +1 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −193,982−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −262−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −34−100.0% | Sold out |